Leap Therapeutics, Inc.
Clinical trials sponsored by Leap Therapeutics, Inc., explained in plain language.
Leap Therapeutics, Inc.
LPTX
NASDAQ
Clinical-stage biopharmaceutical company developing cancer immunotherapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.